Home/Investors/Deerfield Management

Deerfield Management

Biotech Investor · 2 portfolio companies

Portfolio

2

Combined Value

$5.4B

Focus Areas

8

Top Stage

Phase 3

Investment Focus

Cardiovascular Metabolic Diseases Dyslipidemia Rare Diseases Oncology Neurology Cardiology Prenatal Health

Portfolio Companies

Company	Stage	Valuation	Focus
NewAmsterdam Pharma Company	Phase 3	$3.3B	Cardiovascular, Metabolic Diseases
GeneDx Holdings	Commercial	$2.0B	Rare Diseases, Oncology

Frequent Co-Investors

Medicxi1 shared BVF Partners1 shared Frazier Life Sciences1 shared Forbion1 shared Ascendant BioCapital1 shared LSP1 shared Population Health Partners1 shared Casdin Capital1 shared